共 97 条
[1]
Kousha M(2011)Pulmonary aspergillosis: a clinical review Eur Respir Rev 20 156-174
[2]
Tadi R(2001)Aspergillosis case-fatality rate: systematic review of the literature Clin Infect Dis 32 358-366
[3]
Soubani AO(2010)The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients Int J Antimicrob Agents 36 531-536
[4]
Lin SJ(2002)Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients Clin Infect Dis 34 909-917
[5]
Schranz J(2007)Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality Clin Infect Dis 44 531-540
[6]
Teutsch SM(2011)Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States Mycoses 54 e301-e312
[7]
Perkhofer S(2009)The economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups Int J Infect Dis 13 24-36
[8]
Lass-Florl C(2008)Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America Clin Infect Dis 46 327-360
[9]
Hell M(1998)Invasive Aspergillosis Clin Infect Dis 26 781-803
[10]
Marr KA(2009)Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies Clinicoecon Outcomes Res 1 35-43